Mirum Pharmaceuticals Inc
MIRM
Market Cap$1.26B
Close$
$27.50
6.1% upside
Current Fair Value
6.1% upsideUndervalued by 6.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.26 Billion |
|---|---|
| Enterprise Value | $1.26 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-3.67 |
| Beta | 0.0 |
| Outstanding Shares | 47,133,021 |
| Avg 30 Day Volume | 542,970 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.93 |
|---|---|
| PEG | 49.26 |
| Price to Sales | 6.48 |
| Price to Book Ratio | 6.48 |
| Enterprise Value to Revenue | 5.63 |
| Enterprise Value to EBIT | -11.64 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 1.31 |
Revenue Sources
No data
Insider Trades
ESG Score
No data